Sfoglia per RIVISTA
MULTIPLE SCLEROSIS JOURNAL - EXPERIMENTAL, TRANSLATIONAL AND CLINICAL
Collezione AOU San Luigi di Orbassano

  

Items : 1

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years. in Multiple sclerosis journal - experimental, translational and clinical / Mult Scler J Exp Transl Clin. 2020 Dec 18;6(4):2055217320972137. doi: 10.1177/2055217320972137. eCol

2020
AOU San Luigi di Orbassano

Firmino I; Cavalier SJ; Freedman MS; Bertolotto A; Boster A; Horáková D; Jacobs AK; Thangavelu K; Daizadeh N; Poole EM; Baker DP; Margolin DH; Ziemssen T;